BRIEF published on 07/09/2025 at 03:32, 1 year 4 months ago BioNxt Solutions Innovates Targeted Chemotherapy Drug Delivery Precision Oncology Drug Delivery BioNxt Solutions Pharmaceutical Innovations Targeted Chemotherapy
BRIEF published on 07/09/2025 at 03:32, 1 year 4 months ago BioNxt Solutions innove dans l'administration ciblée de médicaments de chimiothérapie Oncologie De Précision Solutions BioNxt Administration De Médicaments Innovations Pharmaceutiques Chimiothérapie Ciblée
PRESS RELEASE published on 07/09/2025 at 03:27, 1 year 4 months ago BioNxt Solutions Introduces Targeted Chemotherapy Drug Delivery Platform for Precision Oncology BioNxt Solutions Inc. announces breakthrough targeted chemotherapy delivery platform for precision oncology, focusing on tumor-specific drug release and neutralization mechanism Precision Oncology BioNxt Solutions Inc. Drug Delivery Targeted Chemotherapy Chemotherapy Market
BRIEF published on 07/07/2025 at 09:10, 1 year 4 months ago BioNxt Advances Sublingual Cladribine Program for MS Pharmaceutical Development Multiple Sclerosis Treatment BioNxt Solutions Sublingual Cladribine Patient Compliance
BRIEF published on 07/07/2025 at 09:10, 1 year 4 months ago BioNxt fait progresser le programme de cladribine sublinguale pour la sclérose en plaques Développement Pharmaceutique Solutions BioNxt Cladribine Sublinguale Conformité Des Patients Traitement De La Sclérose En Plaques
PRESS RELEASE published on 07/07/2025 at 09:05, 1 year 4 months ago BioNxt's Sublingual Cladribine Program for MS Ready for Next Phase BioNxt Solutions receives cladribine API for BNT23001 sublingual thin-film formulation treating multiple sclerosis. Initiates clinical batch production with European partner Gen-Plus GmbH & Co KG Multiple Sclerosis BioNxt Solutions BNT23001 Cladribine API Sublingual Film
BRIEF published on 06/28/2025 at 01:55, 1 year 4 months ago BioNxt Solutions MCTO Revoked by British Columbia Securities Commission Cease Trade Order Annual Filings Trading Resumption Securities Commission BioNxt Solutions
BRIEF published on 06/28/2025 at 01:55, 1 year 4 months ago La Commission des valeurs mobilières de la Colombie-Britannique a révoqué l'autorisation de mise sur le marché de BioNxt Solutions. Dépôts Annuels Commission Des Valeurs Mobilières Solutions BioNxt Reprise Des Échanges Ordonnance De Cessation D'opérations
PRESS RELEASE published on 06/28/2025 at 01:50, 1 year 4 months ago BioNxt Solutions Announces Revocation of Management Cease Trade Order BioNxt Solutions Inc. announces revocation of management cease trade order by British Columbia Securities Commission after filing annual financial statements. Company focuses on bioscience drug technologies Financial Statements Management Cease Trade Order BioNxt Solutions Inc. BioScience Drug Technologies
BRIEF published on 06/23/2025 at 09:10, 1 year 4 months ago BioNxt Explores New Delivery Method for Semaglutide with Feasibility Study Feasibility Study Drug Delivery BioNxt Solutions Semaglutide GLP-1 Therapy
Published on 11/10/2026 at 02:45, 2 hours 21 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 5 hours 56 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 6 hours 6 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 6 hours 34 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 6 hours 51 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 04:55, 11 minutes ago The 19th Europe-China Business and Technology Cooperation Fair boosts business cooperation
Published on 11/10/2026 at 01:20, 3 hours 46 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 22:54, 6 hours 12 minutes ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 6 hours 56 minutes ago Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 18:30, 10 hours 36 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 10 hours 36 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 11 hours 21 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 11/09/2026 at 17:45, 11 hours 21 minutes ago Déclaration des droits de vote à fin octobre 2026
